Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Net Cash Flow (2022 - 2023)

Bluejay Diagnostics' Net Cash Flow history spans 2 years, with the latest figure at -$2.9 million for Q4 2023.

  • For Q4 2023, Net Cash Flow rose 9.87% year-over-year to -$2.9 million; the TTM value through Dec 2023 reached -$7.9 million, up 11.57%, while the annual FY2024 figure was $2.1 million, 126.48% up from the prior year.
  • Net Cash Flow for Q4 2023 was -$2.9 million at Bluejay Diagnostics, down from -$23470.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at -$23470.0 in Q3 2023 and bottomed at -$3.3 million in Q1 2023.